Umbilical cord-derived mesenchymal stromal cell therapy (Cells for cells)

N/A

Report date: 2023/01/12 15:31:45

Base Information

Drug NameUmbilical cord-derived mesenchymal stromal cell therapy (Cells for cells)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLupus Erythematosus, SystemicLupus Nephritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryChile

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCells For Cells

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of The Andes, Chile

Inactive CompaniesN/A

Active IndicationsLupus Erythematosus, SystemicLupus Nephritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A